Figure 1. A, sensitivity of a panel of 12 pancreatic tumor cell lines to growth inhibition by erlotinib. Cell lines show a continuum of sensitivities to erlotinib. Cell lines were divided into three groups (sensitive, intermediate, and insensitive) based on their maximal percentage growth inhibition by 10 mmol/L erlotinib.